The Legal and Ethical Debate on Human Heritable Genome Editing (HHGE) in South Africa
By Jantina de Vries,
EthicsLab
| 11. 15. 2024
The conversation around human heritable genome editing (HHGE) in South Africa is marked by controversy and conflicting interpretations of the law. At the center of this debate lies a team of lawyers based at a South African university, who have long championed a highly liberal stance toward reproductive technologies, including HHGE. Their assertions, however, have raised significant concerns among South Africa’s legal, ethical, and scientific communities.
Is heritable human genome editing already legal in South Africa?
This team has made the controversial claim that HHGE is already legal in South Africa – a position that has gained significant national and international outrage in recent days. As a non-lawyer, I have struggled to make sense of their argument which seems highly technical. Let me try to explain what I think they are saying.
Their argument seems to hinge on a specific interpretation of the National Health Act, which prohibits genetic modification for the purposes of reproductive cloning. They seem to argue that the term "reproductive" in the law should be read to refer to the purpose of the genetic manipulation –...
Related Articles
Cathy Tie seems to be good at starting businesses but not so dedicated to maintaining them. CGS, like many others, first heard of her thanks to Caiwei Chen and Antonio Regalado in MIT Technology Review, May 2025, as the partner (perhaps bride) of the notorious Chinese scientist He Jiankui, described in the headline as “China’s Frankenstein.” He prefers “Chinese Darwin.” She ran his Twitter account for a while, contributing such gems as:
Get in luddite, we’re going gene editing...
By Laura DeFrancesco, Nature Biotechnology | 03.17.2026
The first gene editors designed to fix genetic lesions in mutation-agnostic ways are poised to enter the clinic. Tessera Therapeutics and Alltrna, two Flagship Pioneering-funded companies, are gearing up to test novel genetic medicines in humans. Tessera received regulatory clearance...
By Darren Incorvaia, Fierce Biotech | 03.11.2026
A new method for safely inserting large chunks of DNA into genomes has now measured up in mice, potentially paving the way for the next generation of gene editing medicines.
The approach, which is described in a Nature paper...
By Carolyn Riley Chapman and Nirvan Bhatia, Hastings Bioethics Forum | 03.12.2026
Last year, researchers saved an infant named KJ from a life-threatening rare metabolic disorder using a customized gene editing therapy. This was the first time that an individualized gene therapy was used to treat a human patient, and it has...